Short sleep duration and the risk of nonalcoholic fatty liver disease/metabolic associated fatty liver disease: a systematic review and meta-analysis

被引:0
作者
Jie Yang
Kuo Zhang
Ziwei Xi
Yue Ma
Chunli Shao
Wenyao Wang
Yi-Da Tang
机构
[1] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases
[2] Peking University Third Hospital,Department of Cardiology and Institute of Vascular Medicine, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education
来源
Sleep and Breathing | 2023年 / 27卷
关键词
Short sleep duration; NAFLD; MAFLD;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1985 / 1996
页数:11
相关论文
共 263 条
[1]  
Younossi Z(2018)Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention Nat Rev Gastroenterol Hepatol 15 11-20
[2]  
Anstee QM(2019)Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis Hepatology 70 1119-1133
[3]  
Marietti M(2018)Mechanisms of NAFLD development and therapeutic strategies Nat Med 24 908-922
[4]  
Hardy T(2019)Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis Hepatology 69 2672-2682
[5]  
Henry L(2020)MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease Gastroenterology 158 1999-2014.e1991
[6]  
Eslam M(2021)Short sleep duration among infants, children, and adolescents aged 4 months-17 years - United States, 2016–2018 MMWR Morb Mortal Wkly Rep 70 1315-1321
[7]  
George J(2017)Sleep duration and patterns in Chinese older adults: a comprehensive meta-analysis Int J Biol Sci 13 682-689
[8]  
Bugianesi E(2020)Sleep problems among Chinese adolescents and young adults during the coronavirus-2019 pandemic Sleep Med 74 39-47
[9]  
Zhou F(2016)Prevalence of healthy sleep duration among adults–United States, 2014 MMWR Morb Mortal Wkly Rep 65 137-141
[10]  
Zhou J(2019)Short sleep duration and cardiometabolic risk: from pathophysiology to clinical evidence Nat Rev Cardiol 16 213-224